The reiteration of an Outperform rating and a maintained price target of $20 by a reputable analyst like Sean Dodge from RBC Capital is likely to instill confidence among investors and could lead to a positive short-term impact on Sotera Health's stock price. Analyst ratings, especially from well-regarded financial institutions, can significantly influence investor sentiment and stock prices.